China: China Amends Patent Law

Last Updated: 27 October 2009
Article by Weishi Li

Originally published January 7, 2009

The PRC Patent Law was first promulgated in 1984 and has since been amended twice, in 1992 and 2000. Last week, on December 27, 2008, China passed the Third Amendment to the PRC Patent Law (the "New Patent Law"), which will become effective on October 1, 2009. In connection with this, a Draft Amendment to Implementing Regulations of the PRC Patent Law (the "Draft Implementing Regulations") was issued by the State Intellectual Property Office for public comments on November 4, 2008.

We highlight below a number of important changes in the New Patent Law:

  • Genetic Resources. The New Patent Law, through amendments to Article 5 and Article 26, regulates the use of genetic resources in China to develop inventions. Under the amended Article 5 of the New Patent Law, if the acquisition or use of genetic resources violates relevant laws and regulations of China, then no patent will be granted for any invention that relies upon such genetic resources. The amended Article 26 further requires that, for an invention that relies on such genetic resources, an applicant must disclose in the patent application the direct and the original source of such genetic resources, and if the applicant cannot identify the original source, he or she must specify reasons for the failure to do so. Failure to comply with such disclosure requirements could result in the denial or invalidation of a patent, as proposed by the Draft Implementing Regulations.
  • Double Patenting. The amended Article 9 of the New Patent Law now expressly provides that only one patent may be granted for a single invention. It has been common for an applicant to file for both an invention patent and a utility model patent for the same invention on the same day, and obtain a utility model patent first and an invention patent later. The amended Article 9 requires that such applicant must abandon the active utility model patent before an invention patent can be issued for the same invention.
  • Joint Ownership. The existing Patent Law is silent on the rights of joint owners of patents and patent applications. The New Patent Law now includes a new provision (Article 15) that specifies the rights of joint owners of patents and patent applications. Article 15 provides that, unless otherwise agreed upon by joint owners, a joint owner is entitled to exploit the jointly-owned patent alone or grant a non-exclusive license to a third party to exploit such patent. Any fees generated from such license must be shared among all joint owners. All other types of exploitation of a jointly-owned patent or patent application must be agreed upon by all joint owners. Therefore, under the New Patent Law, assigning or granting exclusive license to a jointly-owned patent or patent application must be agreed upon by all joint owners of such patent or patent application.
  • Inventions Made In China. Under the existing Patent Law, for inventions made in China, Chinese companies and individuals must make China patent filings first before they can make foreign filings (the so-called "first-file-in-China" rule). The amended Article 20 of the New Patent Law now provides that, for an invention or utility model made in China, any applicant (not just Chinese companies and individuals), before filing a patent application outside of China, must first submit it to the patent department under the State Council for a confidential examination in accordance with the relevant provisions of the State Council. Failure to comply with this requirement will result in the denial of any Chinese patent for the invention. This is a significant change from the current rule in two aspects: (i) under the existing rule, foreign companies and individuals arguably are not bound by the first-file-in-China rule, whereas the new rule binds everyone; and (ii) the new rule replaces the first-to-file-in-China requirement with a requirement for confidential examination by the State Council before any foreign filing can be made. This added requirement of confidential examination by the State Council creates uncertainty for applicants. The procedures and timelines for such confidential examination are not set forth in the New Patent Law, but are instead covered in the Draft Implementing Regulations, which will be subject to further changes before it comes into effect.
  • Novelty Bar. Under the existing Patent Law, prior use or prior knowledge outside China does not constitute a novelty bar for invention patents and utility model patents. The amended Article 22 of the New Patent Law elevates the novelty criteria to an "absolute novelty standard". Under the new standard, to be considered "novel", an invention must be unknown to the public both in China and abroad prior to the date of filing. In addition, under the amended Article 22, an identical invention or utility model disclosed in an earlier application by the same applicant prior to the filing date of a later application can be used as a novelty bar against any later application. Similar elevated novelty standards have also been adopted for design patents. These changes overall aim to reduce the number of frivolous patents and generally improve the quality of granted patents.
  • Compulsory License. The New Patent Law sets forth more detailed rules for compulsory licenses, as compared to the existing Patent Law. Under the New Patent Law, the government may grant a compulsory license to a third party to use the patent, if (i) a patent holder has failed, without justification, to exploit or sufficiently exploit the patent within three years after the issuance of the patent and four years after the filing of the patent application (note that this does not apply to semiconductor patents), or (ii) the exploitation of the patent is deemed as monopolistic behavior according to the law. Furthermore, for the purpose of public health, the government may grant compulsory licenses for manufacturing and exporting patented pharmaceuticals to certain countries and regions. Although no compulsory license grant has ever been reported in practice since the Patent Law was first implemented in 1984, the introduction of more detailed rules for granting compulsory licenses in the New Patent Law raises the possibility that compulsory licenses may be granted in the future.
  • Prior Art Defense. Under the current practice in China, in a patent infringement suit, a court will determine whether there is an infringement, but invalidation examination (if requested by the defendant) must be made by the Chinese Patent Reexamination Board (the "CPRB"). When an invalidation request is filed with the CPRB in a patent litigation, the court will typically wait for the CPRB decision before proceeding further, resulting in a prolonged process. The newly added Article 62 now provides that, in a patent infringement suit, if the alleged infringer can prove that the alleged infringing technology or design was already known to the public prior to the filing date of the subject patent, no infringement would be found. Therefore, under the New Patent Law, the alleged infringer may choose to defend against the infringement claim on the basis of prior art in court, thereby expediting the entire proceeding. However, the New Patent Law is silent on whether courts can in fact make invalidation decision or only non-infringement findings. Furthermore, if courts may make invalidation decisions, this rule may potentially lead to (i) conflicting results among different courts over the same patent, and (ii) if an invalidation proceeding is brought to the CPRB over the same patent, conflicting results between courts and the CPRB.
  • Regulatory Review Exemption. The New Patent Law provides an express infringement exemption for activities related to obtaining information for regulatory approval for drugs and medical devices (Article 69, clause 5), including making, using and importing a patented drug or patented medical devices. This exemption is currently available through judicial interpretation of the experimental use exception under the existing Patent Law.

Overall, New Patent Law is generally moving in the direction of strengthening protection for patents and elevating standards for Chinese patents, indicating the Chinese government's intent of encouraging innovation and creation. However, as noted above, certain areas of the New Patent Law will benefit from further clarifications, which will hopefully be provided in the upcoming amended Implementing Regulations of the PRC Patent Law.

O'Melveny & Myers LLP routinely provides advice to clients on complex transactions in which these issues may arise, including finance, mergers and acquisitions, and licensing arrangements. If you have any questions about the operation of the applicable statutory provisions or the case law interpreting these provisions, please contact any of the attorneys listed on this alert.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions